Burkholderia mallei and Burkholderia pseudomallei are Gram-negative, rod-shaped bacteria, and are the causative agents of the diseases glanders and melioidosis, respectively. These bacteria have been recognized as important pathogens for over 100 years, yet a relative dearth of available information exists regarding their virulence determinants and immunopathology. Infection with either of these bacteria presents with nonspecific symptoms and can be either acute or chronic, impeding rapid diagnosis. The lack of a vaccine for either bacterium also makes them potential candidates for bioweaponization. Together with their high rate of infectivity via aerosols and resistance to many common antibiotics, both bacteria have been classified as category B priority pathogens by the US NIH and US CDC, which has spurred a dramatic increase in interest in these microorganisms. Attempts have been made to develop vaccines for these infections, which would not only benefit military personnel, a group most likely to be targeted in an intentional release, but also individuals who may come in contact with glanders-infected animals or live in areas where melioidosis is endemic. This review highlights some recent attempts of vaccine development for these infections and the strategies used to improve the efficacy of vaccine approaches.
Keywordsbioweapon; Burkholderia; glanders; immunization; melioidosis; vaccine
Infections caused by Burkholderia mallei & Burkholderia pseudomalleiBurkholderia mallei and Burkholderia pseudomallei cause the diseases glanders and melioidosis, respectively. While these bacteria are phylogenetically similar, their lifestyles and epidemiology are quite divergent. Specifically, B. mallei is an obligate mammalian pathogen that typically infects solipeds, such as horses, mules and donkeys, and only occasionally infects humans. Individuals most at risk of contracting the disease are animal handlers in close contact with infected creatures and those who ingest contaminated meat. Glanders was effectively eradicated in North America and Western Europe in the 1950s by the mass culling of infected animals, but remains in the equine population of Africa, Asia, the Middle East and Central and †Author for . This fact may help explain the long periods of latency observed in some infections. It is likely that intracellular replication and survival may also provide the bacteria with a means for evading the humoral immune system. Such factors should be taken into account when developing possible vaccine strategies.The high rate of infectivity via aerosols, their resistance to many common antibiotics and the absence of a vaccine for either infection make these bacteria of great concern as modern bioterror agents. Indeed, B. mallei is a proven bioweapon that was used in both World Wars I and II. It has been suggested that the former Soviet military used this agent more recently in Afghanistan and that they were also weaponizing B. pseudomallei [15]. With respect to natural infection with B. pseudomallei, even when th...